SecBot SecBot
144 ·Filed Nov 12, 2026

SEPN

Septerna, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4d 4h ago SEC0001628280-26-073519
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for actual sale execution on Form 4 filings. The proposed sale by a pre-IPO investor may signal a desire to take profits post-IPO, but the filing alone does not confirm the sale will occur.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$42.60
T+0 close · Nov 12, 2026 · via day close
Latest settled
−2.18%
T+1 · $41.67
Vs SPY
−0.27%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $42.60entry
  2. T+1 · 15h ago −2.18%α −0.27% · $41.67
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Samsara BioCapital, L.P., a significant shareholder in Septerna, filed a Form 144 notice of intent to sell 306,645 shares of common stock, with an approximate market value of $14.9 million. This represents a notable insider sale by a pre-IPO investor, though it is only an intent to sell and may not be executed.

Key Facts

  • Samsara BioCapital, L.P. filed Form 144 on November 12, 2026
  • Proposed sale of 306,645 shares of Septerna common stock
  • Estimated aggregate market value of $14,890,681.20 based on a price of $48.55 per share
  • Shares were acquired on October 25, 2024 in the IPO
  • Samsara BioCapital is a venture capital firm and pre-IPO investor
  • The filing is an advance notice of intent to sell, not a completed transaction

Financial Impact

Up to 306,645 shares sold, valued at approximately $14.9 million based on the filing price

dilutioninsider selling

Risk Factors

  • Insider selling by a significant pre-IPO shareholder could pressure the stock if executed
  • Form 144 is only an intent to sell; the actual sale may not happen or may be at different terms

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-073519
Document: 0001628280-26-073519-index.html0001628280-26-073519
Document: 0001628280-26-073519.txt0001628280-26-073519

Track record

25 reports on SEPN

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 16, 2026today 144 Neutral 2/10 Entry price pending
  3. Nov 12, 20264d ago 144 Neutral 3/10 Viewing Entry $42.60 Now $41.67 −2.18% settles Nov 20
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
  5. Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $41.67 −0.45% settles Nov 19
  6. Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
  7. Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
  8. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
  9. Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
  10. Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (11h 18m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026